Expanded 10-plus-year collaboration will leverage Medidata Experiences with the goal of streamlining clinical processes and data, enhancing patient care NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Medidata , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced an extension of their collaboration with Sanofi in clinical research. As part of this extension... Read More

Expanded 10-plus-year collaboration will leverage Medidata Experiences, enabling Sanofi to streamline operations, refine data quality, and enhance patient care NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Medidata , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, and Sanofi today announced an expansion of their partnership to bolster clinical research. This new... Read More

In the news release, Sanofi's high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose, issued 21-Oct-2025 by Sanofi-Aventis Canada Inc. over CNW, a footnote "*The standard-dose influenza vaccines used in the FLUNITY-HD study were VaxigripTetra (Sanofi) and InfluvacTetra (Viatris). Standard-dose vaccines often serve as the primary influenza prevention option for... Read More

Compared to standard-dose influenza vaccines, Fluzone High-Dose Influenza Vaccine demonstrated a reduction in laboratory-confirmed influenza hospitalizations by an additional 31.9% (95% CI, 19.7 to 42.2; p<0.001) in adults 65 years and over Results come from FLUNITY-HD, the largest influenza vaccine effectiveness study of individually randomized older adults, involving nearly half a million participants across several... Read More

CHICAGO , Oct. 16, 2025 /PRNewswire/ -- EVOQ Therapeutics, Inc. (EVOQ), a biotechnology company focused on delivering transformative cures for those living with autoimmune diseases, today announced a Collaboration and License Agreement with Sanofi , an R&D driven, AI-powered biopharma company, committed to improving people's lives and delivering compelling growth. Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY EVOQ's... Read More

MORRISTOWN, N.J. , Sept. 26, 2025 /PRNewswire/ -- Sanofi US today announces a broad expansion of its Insulins Val you Savings Program by offering a 30-day supply of any Sanofi insulin for $35 to all patients in the US with a valid prescription. The program, first created for people without health insurance, will be available to all Americans regardless of insurance status, including those with commercial insurance or... Read More

Mandy Moore joins Elaine Welteroth , Gaby Dalkin , Katya Echazarreta , and Shawn Johnson East to share their personal respiratory syncytial virus (RSV) stories and why they chose BEYFORTUS to help protect their babies from serious RSV lung infection They join the millions of parents in the US who have chosen BEYFORTUS to help protect their babies from RSV, the number one reason babies under 1 are hospitalized MORRISTOWN,... Read More

BOSTON , Aug. 26, 2025 /PRNewswire/ -- In recognition of National Community Health Worker (CHW) Awareness Week, a new report, Strengthening Public Health with Community Health Workers , #StrengthInCHWs, was published today that spotlights examples of sustained programs in communities across the country where the trust and expertise of CHWs is strengthening health interventions - from outreach to community engagement, and... Read More

87% reduction in cases of respiratory syncytial virus (RSV) disease across all sites of care among healthy, term babies, born ahead of or during the RSV season 98% reduction in hospitalizations of babies with RSV compared to those who did not get BEYFORTUS, per new post-hoc analysis MORRISTOWN, N.J. , July 22, 2025 /PRNewswire/ -- The largest US real-world study of BEYFORTUS (nirsevimab-alip) 50mg and 100mg Injection... Read More

New fund supports nonprofit partners working to address social drivers of health and strengthen community well-being CAMBRIDGE, Mass. , June 26, 2025 /PRNewswire/ -- Sanofi today announced it has awarded over $1 million in grants through its inaugural Healthy Futures Solution Fund to support local nonprofits across Massachusetts that are advancing community-led solutions to improve health and well-being in historically... Read More

TORONTO , June 9, 2025 /CNW/ - Sanofi Canada today announced the appointment of James Guy as Country Lead, Canada and General Manager, Specialty Care. In this role, Guy will lead Sanofi's Canada Country Council, which manages the operations of the company's three business units and functions. Guy will also head the Specialty Care business unit in Canada . James Guy Country Lead, Canada and General Manager, Specialty Care... Read More

MORRISTOWN, N.J. , May 22, 2025 /PRNewswire/ -- Sanofi today announces the formal opening of the company's new flagship US offices, unveiling a state-of-the-art modern workplace fostering collaboration and innovation with the ultimate goal of bringing medicines and vaccines to patients faster. New Jersey Governor Phil Murphy and Morristown officials were expected to attend the ribbon-cutting ceremony along with Sanofi CEO... Read More

MORRISTOWN, N.J. and CAMBRIDGE, Mass. , May 14, 2025 /PRNewswire/ -- Sanofi today announces its intention to invest at least $20 billion in the United States through 2030. The expected investment includes a significant increase in research and development spending and the allocation of billions of dollars to US manufacturing. The announcement comes as Sanofi prepares for the potential launch of numerous new first- or... Read More

Teigen to advocate for the importance of type 1 diabetes screening after son's diagnosis was uncovered during an unexpected medical emergency Screen For Type 1 movement continues momentum into year two with the goal of encouraging people to screen early; just one blood test can spot type 1 diabetes before symptoms occur MORRISTOWN, N.J. , April 15, 2025 /PRNewswire/ -- Sanofi , a leader in diabetes care, welcomes author,... Read More

BRIDGEWATER, N.J. , March 14, 2025 /PRNewswire/ -- Sanofi announced today the immediate adoption of influenza strains selected by the US Food and Drug Administration (FDA) to advance the manufacturing and delivery of its vaccine portfolio for the 2025-26 flu season in the US. As the world leader in flu vaccines, Sanofi had already begun its annual production of vaccines to ensure that robust supply is ready for the coming... Read More

US FLUBLOK label 1 updated to incorporate new safety study in pregnant individuals New safety data involving more than 48,000 pregnant individuals published in American Journal of Obstetrics and Gynecology (AJOG) Global Reports Recombinant or inactivated flu vaccines are recommended by the U.S. Centers for Disease Control and Protection (CDC), Advisory Committee on Immunization Practices (ACIP) and American College of... Read More

BRIDGEWATER, N.J. , Oct. 16, 2024 /PRNewswire/ -- Sanofi announced today it will contribute $18 million to three Historically Black Medical Schools to help the institutions work to increase diversity in clinical studies. The investment over 10 years is aimed at strengthening Centers of Excellence in clinical study diversity at Howard University College of Medicine, Meharry Medical College , and Morehouse School of Medicine.... Read More

Company planning for every eligible baby in the US to have access to BEYFORTUS New BEYFORTUS filling line approved by the U.S. Food and Drug Administration (FDA) to expand manufacturing capacity and help meet demand 2 out of 3 babies get respiratory syncytial virus (RSV) disease 1 BRIDGEWATER, N.J. , Sept. 16, 2024 /PRNewswire/ -- Sanofi is shipping BEYFORTUS (nirsevimab-alip) 50mg and 100mg Injection doses in the US to... Read More

Customers will start receiving shipments from July 10 with additional shipments through October to healthcare provider offices, pharmacies and other immunizers to support fall immunization campaigns. Sanofi annual higher-dose influenza (flu) vaccinations have been proven to help protect from flu and shown to better protect from serious complications of flu such as pneumonia and cardiac events when compared to standard dose... Read More

CAMBRIDGE, Mass. , Nov. 2, 2023 /PRNewswire/ -- Sanofi has announced the winners of its 2023 Health Equity Accelerator Awards , honoring 10 nonprofit organizations that exemplify the company's ambition to provide equitable access to healthcare using innovative solutions for hard-to-solve health disparities. The winning advocacy organizations, announced at Sanofi's Trust, Inclusion, and Equity Summit, serve a diverse range of... Read More

Nationwide storytelling movement to showcase diverse voices of the type 1 diabetes community, including internationally recognized stars Usher, Robin Arzón, and Adam Schefter , to share experiences and encourage people to get screened The 1 Pledge movement commences with surround-sound event in New York City's Times Square; continues throughout the year with events and social storytelling Screening for type 1 diabetes can... Read More

Sanofi hosted the founding ceremony of the homeless futsal club ‘Dream’ and organized a friendly match as a part of the Helping Hands program Sanofi employees and ‘Dream’ members interacted through the friendly match Sanofi has carried out social responsibility activities targeting the homeless and housing vulnerable groups since 2011 SEOUL, South Korea / Oct 17, 2023 / Business Wire / Sanofi in Korea[1], the Korean... Read More

Findings reveal people living with hemophilia secretly carry the emotional burdens of the disease and report mental health challenges including anxiety and depression. Data also uncovers a troubling disconnect between the desire of those living with hemophilia to direct the course of their treatment, with lack of inclusion from their providers in that process. NEW YORK , Oct. 10, 2023 /PRNewswire/ -- The Harris Poll , a... Read More

Certain groups are at an increased risk for serious complications from the flu, including adults 50 years of age and older and those with chronic health conditions. Sanofi's two higher-dose influenza vaccines, Fluzone® High-Dose Quadrivalent (Influenza Vaccine) and Flublok® Quadrivalent (Influenza Vaccine), have shown better... Read More

First large consumer healthcare company to earn B Corp Certification Rigorous certification marks significant progress by maker of Allegra®, Icy Hot® BRIDGEWATER, N.J. , July 25, 2023 /PRNewswire/ -- After making strides in environmental sustainability and social impact commitments, Sanofi Consumer Healthcare North America is pleased to announce it has earned B Corp Certification. This designation follows a rigorous... Read More

Recludix to receive $125 million in near-term payments and potentially more than $1.2 billion subject to future milestones, and up to double-digit royalties on sales Recludix to lead research and development until start of Phase 2 Recludix has an option to participate equally in U.S. profit/loss sharing SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) -- Recludix Pharma , a leader in platform approaches to discover inhibitors of... Read More

Decision unanimously affirms the United States Federal Circuit Court's opinion that Amgen's asserted U.S. PCSK9 patent claims are invalid BRIDGEWATER, N.J. , May 18, 2023 /PRNewswire/ -- Sanofi (NASDAQ: SNY) is pleased with the United States Supreme Court's ruling in Amgen v. Sanofi et. al. The decision unanimously affirms the United States Federal Circuit Court's opinion that is favorable to Sanofi and Regeneron. This... Read More

BRIDGEWATER, N.J. , April 4, 2023 /PRNewswire/ - - Sanofi and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), celebrated today the groundbreaking of a new, state-of-the-art formulation and filling facility at Sanofi's Swiftwater site in Pennsylvania . The new formulation... Read More

PARIS , Jan. 18, 2023 /PRNewswire/ -- Sanofi announces at the 53 rd Annual Meeting of the World Economic Forum in Davos the launch of the Sanofi NextGen Scholarship , its first global higher education scholarship program for people from numerous communities underrepresented in healthcare professions. The program will help pay tuition and other expenses at institutions of higher education for students who are part of their... Read More